Cargando…
Staphylococcus aureus Cas9 is a multiple-turnover enzyme
Cas9 nuclease is the key effector of type II CRISPR adaptive immune systems found in bacteria. The nuclease can be programmed by a single guide RNA (sgRNA) to cleave DNA in a sequence-specific manner. This property has led to its widespread adoption as a genome editing tool in research laboratories...
Autores principales: | Yourik, Paul, Fuchs, Ryan T., Mabuchi, Megumu, Curcuru, Jennifer L., Robb, G. Brett |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cold Spring Harbor Laboratory Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6298560/ https://www.ncbi.nlm.nih.gov/pubmed/30348755 http://dx.doi.org/10.1261/rna.067355.118 |
Ejemplares similares
-
Target-dependent nickase activities of CRISPR-Cas nucleases Cpf1 and Cas9
por: Hua Fu, Becky Xu, et al.
Publicado: (2019) -
DNA rehybridization drives product release from Cas9 ribonucleoprotein to enable multiple-turnover cleavage
por: Pan, Juan, et al.
Publicado: (2023) -
Characterization of Cme and Yme thermostable Cas12a orthologs
por: Fuchs, Ryan T., et al.
Publicado: (2022) -
A catalogue of biochemically diverse CRISPR-Cas9 orthologs
por: Gasiunas, Giedrius, et al.
Publicado: (2020) -
An efficient and cost-effective purification protocol for Staphylococcus aureus Cas9 nuclease
por: Teng, Allen C.T., et al.
Publicado: (2022)